Trading Tips Blog

Ares Trading, already a major holder in Precigen (PGEN), recently added another $25 million investment. At that price, the company was able to pick up 6,758,400 shares. That’s a 32 percent increase to the fund’s stake in the company. The move dwarfs the insider sales in the past month from company insiders. The buy comes as shares of the company have dropped from $15 to under $4 in the past two years. Insiders, including Ares Trading, own over 15 percent ...
Read More About This

J.P. Morgan just updated an electric vehicle company. Not only that, but the investment bank gave a price target more than double where shares were trading at the time. That’s a bullish call, and a justified one. That’s because the bank expects the electric vehicle market to continue growing substantially, possibly as much as four times higher in some markets. And, no, the company isn’t Tesla Motors. The company is NIO (NIO), the Chinese play. Although the company isn’t profitable yet ...
Read More About This

Deutsche Bank sees improving trends for DRAM memory. That’s one sector of the tech space that has been held back lately. The push for cloud services has reduced demand for mobile device memory chips, but now that cycle is turning. While there’s some small risk of inventory accumulation leading overall, the rising demand strength in the space, particularly with server demand, could lead to higher prices for DRAM related companies. Deutsche specifically sees value in Micron (MU). Shares were upgraded to ...
Read More About This

Timothy Springer, a director and major owner at Selecta Biosciences (SELB), recently bought 3,185,394 shares of the company. That trade came to over $5.4 million. The buy increased his total holdings to just over 16.05 million shares. Another director made a 50,000 share buy at the start of October as well. There have been some insider sales in the past year, but they have been dwarfed by insider buys. Insiders own 17 percent of all shares of the immunogenetics company. Shares ...
Read More About This

Over 1,950 contracts traded on the November 27th $25 calls on Carnival Cruise (CCL). The prior open interest on the trade was 137 contracts, showing a 14-fold rise in volume. The trade, expiring in 44 days, has a strike price 75 percent higher than where shares currently trade around $14.25. With that big of a price difference, it’s no surprise that the buyer of the contract only paid about $0.13, or just $13 per contract, on average. As it’s unlikely for shares ...
Read More About This

Citigroup recently upgraded one major consumer goods play following a strong earnings beat. Thanks to stay-at-home trends, this company has fared relatively well, even better than peers. That’s led to the view that this company will continue to show strong growth into 2021. Even better, this company lags competitors in terms of operating margins. As a result, shares look likely to offer multiple expansion as well, which could lead to even bigger returns. The company? PepsiCo (PEP). Best known as the second-largest ...
Read More About This

Richard Anderson, a director at Medtronic PLC (MDT), recently added 4,607 shares. The buy came to a total purchase price of nearly $51,000, and increased the director’s stake by 4.4 percent. This is the second insider buy of 2020, following a buy from the company CEO back in February. Insiders have been a mix of buyers and sellers this year. The share price of the company has held up relatively well in the past year. Although sales and earnings are slightly off ...
Read More About This

Nearly 9,100 contracts traded on the June 2021 $640 calls on Tesla Motors (TSLA) recently. That’s a 12-fold rise over the prior open interest of 766 contracts. The trade, expiring in 248 days, would require shares to rally about 45 percent from their current price. The option buyer paid about $51.90, or $5,190 per contract to make the far out-of-the-money trade. Shares of the company have been one of the top performers in the past year. While a 45 percent move in ...
Read More About This